SWX:NOVN.S News 24 January 2026

Novartis stock near a year-high — what investors watch before earnings

Novartis AG closed Friday at 115.64 Swiss francs in Zurich, up 0.47%, trading near its 52-week high. About 2.6 million shares changed hands. U.S.-listed Novartis shares ended at $147.14, rising further after hours. The company reports fourth-quarter and full-year results on Feb. 4.

24 January 2026

Earnings Reports·NYSE:NVS·Pharmaceuticals·Stock Market·SWX:NOVN.S

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026

MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.

LONGi Green Energy stock in focus: 1.65 bln yuan patent fee signals higher costs as China solar outlook softens

8 February 2026

LONGi Green Energy’s Shanghai A-shares closed up 0.7% at 18.36 yuan on Friday after a 1.65 billion yuan BC solar patent licensing deal was disclosed this week. The agreement, involving Aiko Solar and Maxeon, set a price for key solar IP as industry forecasts point to a drop in China’s 2026 new solar installations.

Fabrinet stock price jumps nearly 14%: what FN investors watch before Monday’s open

8 February 2026

Fabrinet shares surged 13.8% to $503.99 Friday after a volatile week, boosted by a strong earnings report and analyst upgrades. The company posted quarterly revenue of $1.13 billion and non-GAAP EPS of $3.36, both above guidance. Barclays raised its price target to $548. U.S. jobs and inflation data next week may influence trading.

OmniVision Class A stock: Hong Kong greenshoe adds shares as stabilisation ends — what to watch next week

8 February 2026

OmniVision Integrated Circuits Group issued 4.94 million extra H shares at HK$104.80 each after underwriters partially exercised an over-allotment option, raising HK$511.2 million. The new shares begin trading in Hong Kong on Feb. 11. The stabilisation period ended Feb. 6. OmniVision’s Shanghai shares closed at 115.95 yuan on Friday, down 1.43%.

SWX:NOVN.S News 24 January 2026

Novartis stock near a year-high — what investors watch before earnings

Stock Market Today

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

LONGi Green Energy stock in focus: 1.65 bln yuan patent fee signals higher costs as China solar outlook softens

Fabrinet stock price jumps nearly 14%: what FN investors watch before Monday’s open

OmniVision Class A stock: Hong Kong greenshoe adds shares as stabilisation ends — what to watch next week